Global Lung Cancer Therapeutics Market To Contribute Around $11.19 Billion During The Period 2016-2020

MarketResearchReports.biz has recently announced the addition of a market study “ Global Lung Cancer Therapeutics Market 2016-2020 ”, is a comparative analysis of the global market.

About Lung Cancer Therapeutics

Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases. It grows and spreads quite slowly.

Technavios analysts forecast the global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global lung cancer therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent lung cancer therapeutics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio’s report, Global Lung Cancer Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/877716

Key vendors

F. Hofmann-La Roche

Eli Lilly

AstraZeneca

Pfizer

Celgene

Other prominent vendors

Abbvie

Aetna

Agennix

Allergan

Amgen

ARIAD Pharmaceuticals

Astellas Pharma

Betta Pharmaceuticals

BeyondSpring Pharmaceuticals

BioNumerik Pharmaceuticals

Boehringer Ingelheim

Boston Biomedical

Bristol-Myers Squibb

Celldex

CTI BioPharma

Eisai

GlaxoSmithKline

GTx

Helsinn

Hutchison Medipharma

Ionis Pharmaceuticals

Kadmon Corporation

MabVax

Merck

Novartis

NovaRx Corporation

OncoGeneX

Ono Pharmaceutical

OSE Immunotherapeutics

OSI Pharmaceuticals

Peregrine

PharmaMar

Pierre Fabre

Qiagen

Recombio

Samsung Bioepis

Sanofi

SFJ Pharmaceuticals

Spectrum Pharmaceuticals

Sumitomo Dainippon Pharma

Synta

Takeda Pharmaceuticals

Teva Pharmaceutical

Xcovery

Market driver

Growing demand for targeted therapies

For a full, detailed list, view our report

Market challenge

Growing popularity of alternative therapeutics

For a full, detailed list, view our report

Market trend

Emergence of nanomedicine platform for the treatment of lung cancer

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Table Of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Disease overview

Understanding the disease

Economic burden

Types of lung cancer

Diagnosis

Staging of SCLC

Staging of NSCLC

Key buying criteria

PART 06: Pipeline analysis

PART 07: Market landscape

Global lung cancer therapeutics market

Five forces analysis

PART 08: Market segmentation by disease type

NSCLC

Global NSCLC market overview

SCLC

Global SCLC market overview

PART 09: Market segmentation by type of molecule

Small molecules

Biologics

PART 10: Geographical segmentation

Lung cancer therapeutics market in Americas

Lung cancer therapeutics market in EMEA

Lung cancer therapeutics market in APAC

PART 11: Market drivers

Growing demand for targeted therapies

Presence of blockbuster drugs coupled with longer patent exclusivities

Advancements in identification of molecular biomarkers increasing patient pool

Paradigm shifts toward the adoption of checkpoint inhibitors

PART 12: Impact of drivers

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Read our latest Press Releases at http://www.marketresearchreports.biz/pressreleases

Contact

State Tower

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA: Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

Email: sales@marketresearchreports.biz

Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net